Floatz logo

FILGRASTIM

Testosterone Greater Than 150 ng/dL

M.D. Anderson Cancer Centerprotein_peptidePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Testosterone Greater Than 150 ng/dL cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
M.D. Anderson Cancer Center
Phase 1CC
DARATUMUMAB
M.D. Anderson Cancer Center
Phase 1CC
DEXAMETHASONE
M.D. Anderson Cancer Center
Phase 1CC
Edicotinib
M.D. Anderson Cancer Center
Phase 1C

Same molecule, other indications

FILGRASTIM is also rated in:

plasma cell myelomaDormant
BBB
Indicative ·
79 / 100
View asset →
Burkitt lymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Hodgkins lymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →